AstraZeneca gets Jefferies backing as broker sees $80bn sales target within reach
AstraZeneca PLC (LSE:AZN, NYSE:AZN), the FTSE 100 pharmaceuticals group, has received fresh backing from Jefferies, which believes its ambition to reach $80...
What's Your Reaction?









